Premium
Molecular analyses of the vasopressin type 2 receptor and aquaporin‐2 genes in Brazilian kindreds with nephrogenic diabetes insipidus
Author(s) -
Rocha Juliane L.,
Friedman Eitan,
Boson Wolfanga,
Moreira Ayrton,
Figueiredo Bonald,
Liberman Bernardo,
de Lacerda Luiz,
Sandrini Romulo,
Graf Hans,
Martins Sonia,
Puñales Marcia K.,
De Marco Luiz
Publication year - 1999
Publication title -
human mutation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.981
H-Index - 162
eISSN - 1098-1004
pISSN - 1059-7794
DOI - 10.1002/(sici)1098-1004(1999)14:3<233::aid-humu6>3.0.co;2-o
Subject(s) - biology , genetics , frameshift mutation , missense mutation , gene , nephrogenic diabetes insipidus , mutation , stop codon , vasopressin
Abstract Nephrogenic diabetes insipidus (NDI) is associated with germline mutations in two genes: vasopressin receptor type 2 (V2(R)) in X‐linked NDI, and the water channel aquaporin‐2, in autosomal‐recessive disease. Genetic heterogeneity is further emphasized by reports of phenotypically abnormal individuals with normal structural genes. We analyzed both genes in five Brazilian families and the aquaporin‐2 gene in two Swedish families with clinical and laboratory diagnosis of NDI, by a combination of denaturing gradient gel electrophoresis (DGGE) and direct DNA sequencing. A novel polymorphism in the aquaporin‐2 gene (S167S), but no disease‐associated mutations in any tested individual from all seven families, was detected. In two Brazilian families, frameshift mutations were detected in the V2(R) gene: one leading to a premature stop after codon 36 and the other to a longer peptide (462 aa instead of the 373 aa wild‐type protein). In two other Brazilian families, probable disease‐associated missense mutations were detected: an alanine to proline at codon 163 (A163P) and an asparagine to aspartic acid at codon 85 (D85N). In one Brazilian family, both genes were structurally normal and the aquaporin‐2 gene was also normal in the two Swedish kindreds. This report further extends the mutational spectrum of NDI and suggests that there are other mutational or epigenetic events inactivating the two known genes or even novel genes that underlie NDI. Hum Mutat 14:233–239, 1999. © 1999 Wiley‐Liss, Inc.